Principles of Anticancer Drug Development

  • Elizabeth Garrett-Mayer

Part of the Cancer Drug Discovery and Development book series (CDD&D)

Table of contents

  1. Front Matter
    Pages i-xvii
  2. Part I

    1. Front Matter
      Pages 1-1
    2. Elizabeth G. Hill, Elizabeth Garrett-Mayer
      Pages 3-35
    3. Daniel L. Gustafson, Erica L. Bradshaw-Pierce
      Pages 37-62
    4. Walter J. Loos, Peter de Bruijn, Alex Sparreboom
      Pages 63-86
  3. Part II

    1. Front Matter
      Pages 87-87
    2. Edward A. Sausville
      Pages 89-114
  4. Part III

    1. Front Matter
      Pages 115-115
    2. Stephen Leong, Justin Call, Alex A. Adjei, Wells Messersmith
      Pages 117-139
    3. Hui K. Gan, J. Jack Lee, Lillian L. Siu
      Pages 141-161
    4. Wendy R. Parulekar, Daniel J. Sargent
      Pages 163-188
    5. Alex Sparreboom, Sharyn D. Baker
      Pages 189-214
    6. D. Ross Camidge, Robert C. Doebele, Antonio Jimeno
      Pages 215-256
    7. Fred R. Hirsch, Yu Shyr
      Pages 257-274
    8. David A. Mankoff
      Pages 275-302
  5. Part IV

    1. Front Matter
      Pages 303-303
    2. Ann T. Farrell, Ramzi N. Dagher, Richard Pazdur
      Pages 305-332
  6. Part V

    1. Front Matter
      Pages 333-333
    2. M. J. A. de Jonge, Jaap Verweij
      Pages 335-345
    3. Laura Q. M. Chow, S. Gail Eckhardt
      Pages 347-401

About this book

Introduction

A practical guide to the design, conduction, analysis and reporting of clinical trials with anticancer drugs.

Keywords

Anticancer Cancer Cancer Research Development Drug

Editors and affiliations

  • Elizabeth Garrett-Mayer
    • 1
  1. 1.Dept. Biostatistics, Bioinformatics &, EpidemiologyMedical University of South CarolinaCharlestonUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-1-4419-7358-0
  • Copyright Information Springer Science+Busines Media, LLC 2011
  • Publisher Name Springer, New York, NY
  • eBook Packages Medicine
  • Print ISBN 978-1-4419-7357-3
  • Online ISBN 978-1-4419-7358-0
  • About this book